J&J Vision unites operations with a solar farm to cover electricity consumption

Article

Company will reduce greenhouse gas emissions globally by 2030

Johnson & Johnson Vision’s operations in Jacksonville, Florida, will be powered by solar energy by 2022, a move that is part of the company's effort to be more sustainable.

Related:First drug-eluting contact lens approved in Japan

100% renewable

The company has signed a 10-year power purchase agreement with solar farm JEA, a community-owned utility, to cover its entire electricity consumption. Johnson & Johnson will purchase electricity from JEA’s ground-mounted solar farms starting in 2022. The move will allow the company to reach its goal of meeting all of its electricity needs with 100% renewables by 2025.

More broadly, J&J aims to reduce greenhouse emissions and reach carbon-neutral operations globally by the end of 2030. It has already made significant progress in this direction, according to reports.1

Related: Tips on fitting new Johnson & Johnson Vision multifocal contact lens

In 2019, the total amount of renewable energy projects made in the U.S. rose to 16GW, up from approximately 10GW in 2018.1 According to an analysis from Bloomberg NEF, a significant portion of the global increase in clean energy procurement was attributed to the U.S.2

References

1. George S. Johnson & Johnson Vision to power global HQ with 100% solar electricity. Edie newsroom. April 28, 2021. Accessed July 27, 2021. https://www.edie.net/news/10/Johnson---Johnson-Vision-to-power-global-HQ-with-100--solar-electricity/

2. Corporate clean energy buying grew 18% in 2020, despite mountain of adversity. BloombergNEF. January 26, 2021. Accessed July 27, 2021. https://about.bnef.com/blog/corporate-clean-energy-buying-grew-18-in-2020-despite-mountain-of-adversity/

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Karen R. Hoffman, OD, speaks on her AOA 2025 poster, which details a case series on fitting patients with irregular cornea and astigmatism with Zenlens (Bausch + Lomb)
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
© 2025 MJH Life Sciences

All rights reserved.